Other specified/unspecified disorders of ear

H8_EARNAS

auditory system disease: Pathological processes of the ear, the hearing, and the equilibrium system of the body.

Suggest a new description

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

520210

1. Apply sex-specific rule

None

520210

2. Check conditions

None

520210

3. Check pre-conditions, main-only, mode, registry filters

Registry filters:

  • Hospital discharge: ICD-10 H93.8, H93.9
  • Hospital discharge: ICD-9 388[8-9]
  • Cause of death: ICD-10 H93.8, H93.9
  • Cause of death: ICD-9 388[8-9]

2 out of 7 registries used, show all original rules.

102

4. Check minimum number of events

None

102

5. Include endpoints

None

102

6. Filter based on genotype QC (FinnGen only)

102

Control definitions (FinnGen only)

Control exclude
H8_OTHEREAR

Extra metadata

Level in the ICD hierarchy
3
First used in FinnGen datafreeze
DF2

Case counts by codes

FinnGen case counts by registry codes:

generic upset plot

Upset plot

Full data table

Summary Statistics

-FinRegistry-

Key figures

All Female Male
Number of individuals
Whole population 846 451 389
Only index persons 716 406 310
Unadjusted period prevalence (%)
Whole population 0.01 0.01 0.01
Only index persons 0.01 0.01 0.01
Median age at first event (years)
Whole population 46.76 50.76 41.95
Only index persons 48.46 51.62 44.31

-FinnGen-

Key figures

All Female Male
Number of individuals 102 72 30
Unadjusted period prevalence (%) 0.02 0.02 0.01
Median age at first event (years) 54.87 53.65 57.82

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

No data

CodeWAS (R11)

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.

Matched cohort

Matched cases
87
Matched controls
868
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
H93.9
ICD-10 Finland
Disorder of ear, unspecified
+∞
48.5
42
*
H93.8
ICD-10 Finland
Other specified disorders of ear
+∞
34.7
31
*
H90.3
ICD-10 Finland
Sensorineural hearing loss, bilateral
114.8
24.1
25
*
DFF00
NOMESCO Finland
Pure tone audiometry
59.8
16.8
19
*
Z01.1
ICD-10 Finland
Examination of ears and hearing
12.8
13.3
24
25
H92.0
ICD-10 Finland
Otalgia
13.7
10.1
17
15
UDC00
NOMESCO Finland
Ear microscopy
12.6
8.7
15
14
3888X
ICD-9 Finland
Other disorders of ear
+∞
8.5
8
*
N07CA01
ATC
betahistine; oral
9.3
7.5
15
19
H90.4
ICD-10 Finland
Sensorineural hearing loss, unilateral with unrestricted hearing on the contralateral side
+∞
7.4
7
*
Z46.1
ICD-10 Finland
Fitting and adjustment of hearing aid
29.0
6.3
8
*
3889X
ICD-9 Finland
Other disorders of ear, Unspecified disorder of ear
+∞
6.3
6
*

LabWAS

OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(3021589) Normoblasts [#/volume] in Blood
59
348
2.65
5.47
8.0
8.7
e9/l
0.0
0.0
0.00
46
281
(3013115) Eosinophils [#/volume] in Blood
66
416
2.66
5.27
4.8
5.9
e9/l
0.2
0.2
0.62
56
373
(3019198) Lymphocytes [#/volume] in Blood
65
416
2.55
4.88
4.7
5.6
e9/l
2.0
1.8
0.76
57
374
(3001604) Monocytes [#/volume] in Blood
63
404
2.46
4.62
4.8
5.6
e9/l
0.6
0.6
0.39
54
354
(3006315) Basophils [#/volume] in Blood
63
405
2.45
4.58
4.8
5.6
e9/l
0.0
0.0
0.98
53
356
(42870588) Differential panel, method unspecified - Blood
43
244
2.32
4.03
5.1
5.5
—
—
—
0
0
(40768795) Lymph node Pathology biopsy report
7
10
7.42
3.42
1.0
1.1
—
—
—
0
0
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
96
837
3.50
2.92
17.2
13.2
mg/l
16.2
22.1
1.55
83
643
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
91
758
2.86
2.90
16.9
12.4
ml/min/173m2
86.5
82.4
0.99
79
591
(3013650) Neutrophils [#/volume] in Blood by Automated count
65
475
2.02
2.87
7.3
10.3
e9/l
4.2
4.1
0.15
56
415
(40758558) Short blood count panel - Blood
36
214
2.05
2.84
5.2
8.2
—
—
—
0
0
(40768804) Tissue Pathology biopsy report
53
362
1.97
2.83
1.9
1.9
—
—
—
0
0
(3044941) Cell count panel - Synovial fluid
5
6
8.68
2.78
1.2
1.3
—
—
—
0
0
(3007853) Bacteria identified in Skin by Aerobe culture
19
89
2.39
2.65
1.6
1.5
—
—
—
0
0
(3050238) Crystals [Presence] in Synovial fluid by Light microscopy
6
13
4.83
2.30
1.3
1.0
—
—
—
0
0
(3044640) Blood type and Crossmatch panel - Blood
39
256
1.85
2.23
2.2
2.1
—
—
—
0
0
(3044290) Cell count panel - Cerebral spinal fluid
6
14
4.48
2.18
1.0
1.7
—
—
—
0
0
(40768797) Stomach Pathology biopsy report
19
97
2.18
2.18
1.4
1.3
—
—
—
0
0
(3002256) Pathology report gross observation
19
99
2.13
2.07
1.2
1.2
—
—
—
0
0
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
77
633
1.88
2.00
4.4
3.9
pmol/l
15.2
14.6
1.28
66
565
(3037467) Urinalysis macro (dipstick) panel - Urine
72
581
1.81
1.97
5.2
3.9
—
—
—
0
0
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
27
163
1.89
1.97
1.9
1.8
mg/l
0.8
0.8
0.03
19
118
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
50
364
1.73
1.97
5.3
6.8
mmol/l
1.2
1.2
1.97
43
308
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
91
796
2.33
1.93
4.3
4.2
mmol/l
5.8
5.9
0.21
79
739
(3004410) Hemoglobin A1c/Hemoglobin.total in Blood
86
737
2.06
1.92
5.6
5.3
mmol/mol
39.2
39.2
0.01
76
695
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
52
385
1.72
1.91
4.0
3.7
—
—
—
0
0
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
42
293
1.74
1.91
3.9
3.2
ng/l
18.2
42.6
1.09
25
190
(3032080) INR in Blood by Coagulation assay
42
294
1.73
1.89
9.8
5.5
inr
1.4
1.2
0.60
13
86
(36304419) Bacteria [Presence] in Urine
34
224
1.78
1.88
3.6
2.8
—
—
—
0
0
(3009542) Hematocrit [Volume Fraction] of Blood
88
762
2.13
1.88
19.8
13.9
%
39.7
39.5
0.09
62
582
(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay
6
17
3.68
1.86
1.2
1.4
—
—
—
0
0
(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay
6
17
3.68
1.86
1.2
1.4
—
—
—
0
0
(3030467) Casts [#/volume] in Urine by Automated count
34
225
1.77
1.85
3.8
3.0
e6/l
0.3
0.6
0.57
26
157
(3024928) Oxygen saturation in Venous blood
5
12
4.32
1.84
1.4
3.1
—
—
—
0
0
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
22
127
1.93
1.83
3.3
3.0
e6/l
2.3
3.6
—
10
57
(3043109) Cytology report of Tissue fine needle aspirate Cyto stain
6
18
3.47
1.77
1.0
1.2
—
—
—
0
0
(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma
36
245
1.73
1.77
3.2
2.4
u/l
143.5
54.9
0.54
31
228
(3018095) Leukocytes [#/volume] in Urine
42
299
1.69
1.75
4.6
3.5
e6/l
136.3
58.8
0.38
31
193
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
42
301
1.67
1.70
1.9
1.9
pmol/l
100.8
96.7
0.13
19
136
(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count
40
283
1.68
1.70
3.5
3.1
—
—
—
0
0
(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma
7
26
2.81
1.61
1.6
1.4
—
—
—
0
0
(3002582) Erythrocytes [#/volume] in Urine
36
251
1.67
1.60
3.8
3.0
e6/l
28.1
49.3
0.39
28
181
(3049717) Cytology report of Urine Cyto stain
7
27
2.71
1.54
1.4
1.9
—
—
—
0
0
(3017895) Helicobacter pylori Ab [Units/volume] in Serum
6
21
2.97
1.53
1.7
1.7
—
—
—
0
0
(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma
23
144
1.77
1.48
4.9
3.5
ng/l
465.8
129.2
0.35
18
98
(3052851) Hemolysis interference index of Serum or Plasma
7
28
2.61
1.48
2.1
2.6
—
—
—
0
0
(3024891) Influenza virus A+B Ag [Presence] in Specimen
7
28
2.61
1.48
1.0
1.2
—
—
—
0
0
(3039162) Centromere protein B Ab [Units/volume] in Serum
5
16
3.23
1.45
1.0
1.3
—
—
—
0
0
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
12
60
2.13
1.45
1.8
1.4
—
—
—
0
0
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
7
29
2.52
1.42
1.7
1.6
—
—
—
0
0
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
28
188
1.67
1.42
2.3
2.3
—
—
—
0
0
(3042936) Bacteria identified in Isolate by Culture
18
106
1.85
1.41
2.0
1.8
—
—
—
0
0
(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain
0
38
0.00
1.37
0.0
1.3
—
—
—
0
0
(36305247) Microscopic observation [Identifier] in Isolate by Gram stain
5
17
3.04
1.37
1.2
1.5
—
—
—
0
0
(3013512) EKG study
31
216
1.63
1.36
4.3
3.6
—
—
—
0
0
(3007164) IgA [Mass/volume] in Serum or Plasma
27
182
1.66
1.34
1.3
1.4
g/l
2.7
2.2
0.56
16
110
(4035726)
14
77
1.95
1.33
1.2
1.3
—
—
—
0
0
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
22
141
1.71
1.31
3.3
2.8
e6/l
0.4
1.2
—
10
70
(3019309) Folate [Moles/volume] in Red Blood Cells
22
141
1.71
1.31
1.8
1.7
nmol/l
1211.1
1216.9
0.01
16
113
(3020044) Glucose [Moles/volume] in Cerebral spinal fluid
5
18
2.87
1.30
1.2
1.3
mmol/l
4.7
3.5
—
5
18
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
68
573
1.56
1.28
3.4
3.2
—
—
—
0
0
(3022145) Colonoscopy Study observation
15
86
1.87
1.27
1.9
1.2
—
—
—
0
0
(3013707) Erythrocyte sedimentation rate by Westergren method
71
607
1.56
1.22
5.1
3.9
mm/h
11.1
11.4
0.08
65
559
(3026008) Bacteria identified in Urine by Culture
35
260
1.53
1.16
3.1
2.7
—
—
—
0
0
(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting
84
751
1.67
1.15
3.5
3.8
mmol/l
1.3
1.2
0.26
75
690
(3012110) Lysozyme [Mass/volume] in Serum or Plasma
5
21
2.45
1.10
1.4
1.6
mg/l
15.1
11.1
—
5
21
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
9
45
2.09
1.08
1.9
1.7
—
—
—
0
0
(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma
7
33
2.20
1.08
1.3
2.1
u/l
40.3
46.0
—
7
28
(3021601) Nitrite [Presence] in Urine by Test strip
51
417
1.45
1.03
5.9
4.7
estimate
0.0
0.0
0.00
12
75
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
88
803
1.70
1.02
4.5
4.7
mmol/l
2.8
2.7
0.59
78
743
(3026493) Urate [Moles/volume] in Serum or Plasma
27
196
1.51
0.98
2.3
3.1
umol/l
302.6
6426.7
1.01
20
170
(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma
15
94
1.70
0.97
4.5
4.3
%
33.4
33.2
—
8
56
(3003458) Phosphate [Moles/volume] in Serum or Plasma
5
101
0.47
0.95
8.2
5.3
mmol/l
1.1
1.1
—
5
91
(3000492) Spirometry study
12
71
1.78
0.93
1.4
1.5
—
—
—
0
0
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
14
89
1.66
0.86
2.0
1.6
—
—
—
0
0
(3045414) Leukocytes [Presence] in Urine
6
31
1.99
0.86
2.8
2.3
—
—
—
0
0
(3035350) Ketones [Presence] in Urine by Test strip
50
418
1.38
0.84
4.2
3.4
estimate
0.0
0.0
0.00
11
74
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
14
90
1.64
0.83
2.0
1.6
—
—
—
0
0
(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma
28
212
1.44
0.82
2.5
3.1
ng/l
851.3
1163.3
0.43
21
181
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
12
74
1.70
0.82
5.2
3.1
—
—
—
0
0
(3037522) Nuclear Ab [Titer] in Serum
16
107
1.59
0.82
1.9
1.3
titre
704.0
634.3
—
5
28
(3001122) Ferritin [Mass/volume] in Serum or Plasma
46
382
1.37
0.80
3.8
2.7
ug/l
89.6
86.2
0.06
41
361
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
85
782
1.52
0.80
4.2
4.2
mmol/l
1.5
1.5
0.30
76
721
(3023368) Bacteria identified in Blood by Culture
27
205
1.43
0.78
6.4
4.2
—
—
—
0
0
(3009261) Glucose [Presence] in Urine by Test strip
50
424
1.35
0.75
4.3
3.5
estimate
0.0
0.0
—
9
69
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
84
774
1.48
0.75
5.2
4.7
mu/l
2.0
1.9
0.58
73
713
(3015736) pH of Urine
40
328
1.36
0.74
3.4
3.3
—
—
—
0
0
(3000330) Specific gravity of Urine by Test strip
7
39
1.85
0.74
3.3
3.8
—
—
—
0
0
(3022217) INR in Platelet poor plasma by Coagulation assay
13
85
1.61
0.73
26.4
25.6
—
1.2
—
0
18
(3013742) Prealbumin [Mass/volume] in Serum or Plasma
11
69
1.67
0.71
2.4
2.2
g/l
0.2
0.2
0.53
11
64
(3004490) Bicarbonate [Moles/volume] standard in Capillary blood
5
26
1.97
0.71
1.6
5.0
mmol/l
24.3
24.4
—
5
26
(3022313) Gas panel - Capillary blood
5
26
1.97
0.71
1.6
4.9
—
—
—
0
0
(4010399)
10
61
1.71
0.71
1.3
1.5
—
—
—
0
0
(3018418) pH of Serum or Plasma
30
237
1.38
0.69
3.7
4.3
ph
7.4
7.4
—
6
43
(3047352) Trisomy 18 risk [Likelihood] in Fetus
5
27
1.89
0.69
2.0
1.4
—
—
—
0
0
(3005033) Fetal Nuchal fold Thickness US
5
27
1.89
0.69
2.0
1.4
—
—
—
0
0
(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum
27
211
1.38
0.66
1.3
1.2
u/ml
0.6
3.5
—
5
53
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
18
131
1.45
0.65
1.8
1.8
—
—
—
0
0
(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection
5
29
1.76
0.64
1.4
1.4
—
—
—
0
0
(3043238) Trisomy 21 risk [Likelihood] in Fetus
5
29
1.76
0.64
2.0
1.6
—
—
—
0
0
(3041096) Erythrocytes [Presence] in Urine by Automated
28
222
1.36
0.63
3.9
3.0
—
—
—
0
0
(3006184) Hemoglobin [Mass/volume] in Capillary blood
0
20
0.00
0.61
0.0
1.7
—
131.5
—
0
12
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
8
53
1.55
0.60
1.0
1.0
—
—
—
0
0
(3016293) Bicarbonate [Moles/volume] in Serum or Plasma
6
37
1.66
0.56
9.2
4.8
mmol/l
25.9
25.4
—
6
37
(3002385) Erythrocyte distribution width [Ratio]
76
701
1.33
0.56
22.8
15.8
%
13.4
13.8
1.66
76
691
(3022621) pH of Urine by Test strip
9
61
1.52
0.55
6.0
2.4
—
—
—
0
0
(3019225) pH of Specimen
9
65
1.42
0.52
3.1
5.0
—
—
—
0
0
(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma
19
146
1.37
0.52
1.6
1.2
iu/ml
11.7
30.5
—
7
56
(3019900) Cholesterol [Moles/volume] in Serum or Plasma
84
790
1.36
0.51
4.1
4.2
mmol/l
4.6
4.6
0.09
76
736
(40761536) Microorganisms panel - Urine sediment
10
68
1.52
0.49
3.5
3.2
—
—
—
0
0
(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma
6
91
0.64
0.45
1.3
1.3
%
1.4
1.4
—
6
77
(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum
18
141
1.34
0.44
1.5
1.2
u/ml
1.3
4.7
—
6
55
(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma
5
31
1.64
0.43
2.0
1.4
—
—
—
0
0
(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight
5
31
1.64
0.43
2.0
1.5
—
—
—
0
0
(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma
5
31
1.64
0.43
2.0
1.5
—
—
—
0
0
(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age
5
31
1.64
0.43
2.0
1.4
—
—
—
0
0
(3047826) Mullerian inhibiting substance [Mass/volume] in Serum or Plasma
0
15
0.00
0.41
0.0
1.1
—
5.2
—
0
15
(3037756) Immunofixation for Serum or Plasma
0
16
0.00
0.41
0.0
1.4
—
—
—
0
0
(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
5
34
1.49
0.41
1.2
2.3
—
—
—
0
0
(4034850)
0
18
0.00
0.40
0.0
11.0
—
—
—
0
0
(3003740) Influenza virus B Ag [Presence] in Specimen
0
18
0.00
0.40
0.0
1.2
—
—
—
0
0
(3002523) Influenza virus A Ag [Presence] in Specimen
0
18
0.00
0.40
0.0
1.2
—
—
—
0
0
(3001019) Free T4 and TSH panel - Serum or Plasma
5
35
1.45
0.40
2.2
2.0
—
—
—
0
0
(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma
5
35
1.45
0.40
2.0
1.7
—
—
—
0
0
(3044889) 12 lead EKG panel
61
561
1.22
0.39
4.0
3.6
—
—
—
0
0
(3018677) aPTT in Platelet poor plasma by Coagulation assay
15
117
1.33
0.38
1.9
2.0
s
29.4
28.9
0.12
15
112
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
36
315
1.22
0.38
4.0
3.6
—
—
—
0
0
(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection
9
71
1.29
0.37
2.1
1.5
—
—
—
0
0
(3050129) First trimester maternal screen panel - Serum or Plasma
6
45
1.35
0.34
1.5
1.4
—
—
—
0
0
(36660697) Celiac disease serology panel - Serum
10
74
1.39
0.34
1.1
1.2
—
—
—
0
0
(3013139) Helicobacter pylori Ag [Presence] in Stool
6
46
1.32
0.33
1.3
1.2
—
—
—
0
0
(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection
7
54
1.32
0.31
1.9
1.4
—
—
—
0
0
(3000494) Fungus identified in Specimen by Culture
12
95
1.30
0.28
1.8
1.5
—
—
—
0
0
(40761535) Cells panel - Urine sediment
8
66
1.23
0.27
2.9
3.3
—
—
—
0
0
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
21
180
1.21
0.26
1.7
1.6
—
—
—
0
0
(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma
18
152
1.22
0.26
2.2
1.6
pmol/l
381.8
465.0
0.97
12
133
(3002032) Base excess in Venous blood by calculation
9
75
1.22
0.26
3.6
3.1
mmol/l
1.9
2.5
—
9
55
(21494755) Public health laboratory ask at order entry panel
9
76
1.20
0.25
1.0
1.3
—
—
—
0
0
(3027946) Carbon dioxide [Partial pressure] in Arterial blood
6
82
0.72
0.25
9.7
6.3
kpa
4.5
5.2
—
6
77
(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma
6
82
0.72
0.25
2.2
1.5
—
—
—
0
0
(3029937) Albumin [Presence] in Urine by Test strip
26
229
1.18
0.25
4.2
3.6
estimate
0.0
0.0
0.00
11
69
(46235355) HIV 1 and 2 tests - Meaningful Use set
21
182
1.19
0.24
1.6
1.8
—
—
—
0
0
(3009343) pH of Capillary blood
5
38
1.33
0.23
1.6
4.0
—
7.4
—
0
5
(3023024) Carbon dioxide [Partial pressure] in Capillary blood
5
40
1.26
0.23
1.6
3.9
kpa
4.8
4.9
—
5
34
(3005082) Progesterone [Moles/volume] in Serum or Plasma
0
10
0.00
0.21
0.0
1.3
—
38.2
—
0
10
(4281824)
0
10
0.00
0.21
0.0
1.0
—
—
—
0
0
(3011397) Hemoglobin [Presence] in Urine by Test strip
24
213
1.17
0.21
4.0
3.4
—
—
—
0
0
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
18
156
1.19
0.20
1.5
1.7
—
—
—
0
0
(3015235) Bicarbonate [Moles/volume] in Capillary blood
0
14
0.00
0.20
0.0
1.7
—
23.4
—
0
8
(3003338) MCHC [Mass/volume]
70
726
0.89
0.17
23.6
17.6
g/l
332.0
331.9
0.02
70
726
(3017732) Neutrophils [#/volume] in Blood
5
67
0.73
0.17
1.8
2.7
e9/l
4.0
3.8
—
5
57
(3012544) pH of Venous blood
9
79
1.15
0.16
3.7
3.0
—
—
—
0
0
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
7
89
0.77
0.15
2.0
1.8
—
—
—
0
0
(3004119) Hemoglobin [Mass/volume] in Venous blood
5
45
1.12
0.10
2.8
2.4
g/l
127.0
129.0
—
5
45
(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma
14
155
0.89
0.10
1.6
3.1
mmol/l
2.5
2.4
0.37
14
135
(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma
7
65
1.08
0.08
1.7
1.5
—
—
—
0
0
(3024561) Albumin [Mass/volume] in Serum or Plasma
36
344
1.07
0.08
4.9
4.4
g/l
35.9
35.9
0.03
36
331
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
9
84
1.08
0.07
1.0
1.6
—
—
—
0
0
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
9
103
0.86
0.06
1.7
1.8
—
—
—
0
0
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
18
169
1.08
0.05
2.2
1.4
—
—
—
0
0
(40760892) CBC W Ordered Manual Differential panel - Blood
21
199
1.07
0.05
3.0
4.6
—
—
—
0
0
(3009508) Creatinine [Moles/volume] in Urine
25
240
1.06
0.04
2.2
2.9
mmol/l
6.0
7.5
1.46
18
205
(3020682) Albumin/Creatinine [Ratio] in Urine
22
229
0.95
0.03
3.8
3.9
mg/mmol
2.7
11.1
—
10
147
(3003694) ABO and Rh group [Type] in Blood
23
239
0.95
0.03
1.7
1.5
—
—
—
0
0
(3019832) Treponema pallidum Ab [Presence] in Serum
12
113
1.07
0.02
1.6
1.6
—
—
—
0
0
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
10
102
0.98
0.00
4.7
7.9
—
—
—
0
0
(3012516) Albumin [Mass/volume] in Urine
22
218
1.01
0.00
2.3
3.1
mg/l
16.8
74.2
—
10
143
(3017143) Hepatitis C virus Ab [Presence] in Serum
11
107
1.03
0.00
1.3
1.5
—
—
—
0
0
(1761868) Lipid panel - Serum or Plasma
28
277
1.01
0.00
4.0
2.7
—
—
—
0
0
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
11
115
0.95
0.00
2.0
2.0
—
—
—
0
0
(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3016724) Homocysteine [Moles/volume] in Serum or Plasma
0
7
0.00
0.00
0.0
1.9
—
11.0
—
0
7
(3029075) Extractable nuclear Ab panel - Serum
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3023419) Bacteria identified in Sputum by Culture
0
9
0.00
0.00
0.0
1.6
—
—
—
0
0
(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence
0
8
0.00
0.00
0.0
1.3
—
—
—
0
0
(3042631) Mycobacterium sp identified in Specimen
0
7
0.00
0.00
0.0
2.6
—
—
—
0
0
(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection
0
7
0.00
0.00
0.0
1.9
—
—
—
0
0
(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(3036481) Cortisol [Moles/volume] in Serum or Plasma
7
74
0.94
0.00
3.6
2.2
nmol/l
282.3
376.7
—
7
66
(3021901) Oxygen saturation in Capillary blood
0
9
0.00
0.00
0.0
2.1
—
—
—
0
0
(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(3005791) Eosinophil cationic protein (ECP) [Mass/volume] in Serum
0
5
0.00
0.00
0.0
1.4
—
16.3
—
0
5
(21494890) Protein electrophoresis panel - 24 hour Urine
0
8
0.00
0.00
0.0
1.9
—
—
—
0
0
(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells
0
7
0.00
0.00
0.0
2.4
—
—
—
0
0
(3048518) aPTT.lupus sensitive actual/normal (normalized LA screen)
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(3041067) Sjogrens syndrome-A extractable nuclear 52kD Ab [Units/volume] in Serum
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection
0
7
0.00
0.00
0.0
2.1
—
—
—
0
0
(3020491) Glucose [Moles/volume] in Blood
0
5
0.00
0.00
0.0
1.4
—
6.1
—
0
5
(40766800) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ T-cells [Units/volume] corrected for background in Blood
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood
0
6
0.00
0.00
0.0
2.3
—
—
—
0
0
(3044242) Glucose [Moles/volume] in Arterial blood
0
6
0.00
0.00
0.0
2.0
—
—
—
0
0
(3030136) 5-Hydroxyindoleacetate [Moles/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
2.5
—
129.0
—
0
6
(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells
0
7
0.00
0.00
0.0
2.4
—
—
—
0
0
(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood
0
6
0.00
0.00
0.0
2.3
—
—
—
0
0
(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(3019060) Gas panel - Arterial blood
5
54
0.92
0.00
1.6
3.3
—
—
—
0
0
(40762485) Glomerular basement membrane Ab [Units/volume] in Serum by Immunoassay
0
9
0.00
0.00
0.0
1.1
—
—
—
0
0
(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum
0
9
0.00
0.00
0.0
1.2
—
—
—
0
0
(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay
0
5
0.00
0.00
0.0
1.6
—
—
—
0
0
(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count
0
6
0.00
0.00
0.0
3.2
—
—
—
0
0
(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection
0
7
0.00
0.00
0.0
1.9
—
—
—
0
0
(3034426) Prothrombin time (PT)
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(40760848) Basement membrane zone BP180 Ab [Units/volume] in Serum by Immunoassay
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(40766048) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum by Immunoassay
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection
0
5
0.00
0.00
0.0
2.0
—
—
—
0
0
(3000081) cloZAPine [Moles/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
4.4
—
2014.8
—
0
5
(3021879) Hepatitis B virus core Ab [Presence] in Serum
7
69
1.02
0.00
1.4
1.5
—
—
—
0
0
(3025018) Bordetella pertussis Ab [Titer] in Serum
0
8
0.00
0.00
0.0
1.1
—
—
—
0
0
(3005570) Glucose [Moles/volume] in Urine
0
9
0.00
0.00
0.0
2.7
—
—
—
0
0
(3027544) Mycobacterium sp identified in Sputum by Organism specific culture
0
9
0.00
0.00
0.0
3.3
—
—
—
0
0
(3006257) Acetylcholine receptor Ab [Moles/volume] in Serum
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3004716) Salmonella sp identified in Stool by Organism specific culture
6
62
0.97
0.00
1.2
1.3
—
—
—
0
0
(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma
7
70
1.00
0.00
2.1
2.1
ug/l
4.9
9.2
—
7
64
(3004588) Protein electrophoresis panel - Serum or Plasma
5
51
0.98
0.00
1.2
2.4
—
—
—
0
0
(3041423) Sjogrens syndrome-A extractable nuclear 60kD Ab [Units/volume] in Serum
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3010503) CD19 cells [#/volume] in Blood
0
5
0.00
0.00
0.0
2.0
—
0.2
—
0
5
(3024666) Lithium, Blood [Moles/volume] in Serum or Plasma
0
7
0.00
0.00
0.0
10.6
—
0.7
—
0
7
(4146454)
0
7
0.00
0.00
0.0
2.6
—
—
—
0
0
(3045788) Cell count panel - Pleural fluid
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(3045683) HLA typing for celiac disease panel - Blood or Tissue
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3053028) Streptococcus sp identified in Specimen by Organism specific culture
0
8
0.00
0.00
0.0
1.1
—
—
—
0
0
(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(3017817) Protein [Mass] in Urine collected for unspecified duration
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(21494434) Karyotype in Bone marrow
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(3019977) pH of Arterial blood
0
7
0.00
0.00
0.0
2.1
—
—
—
0
0
(40760847) Basement membrane Ab [Titer] in Serum by Immunofluorescence
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3000991) Gas panel - Venous blood
6
65
0.92
0.00
10.7
7.3
—
—
—
0
0
(3008832) Norclozapine [Moles/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
4.2
—
1065.6
—
0
5
(3007821) Glucose [Moles/volume] in Serum or Plasma --baseline
0
6
0.00
0.00
0.0
1.2
—
9.0
—
0
6
(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection
0
7
0.00
0.00
0.0
1.9
—
—
—
0
0
(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection
0
5
0.00
0.00
0.0
2.0
—
—
—
0
0
(3035320) C reactive protein [Mass/volume] in Body fluid
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0

Mortality – FinRegistry

Association

Association between endpoint H8_EARNAS and mortality.

Females

No data

Males

No data

Mortality risk

Mortality risk for people of age

years, who have H8_EARNAS.

N-year risk Females Males
1 No data No data
5 No data No data
10 No data No data
15 No data No data
20 No data No data

Relationships between endpoints

Index endpoint: H8_EARNAS – Other specified/unspecified disorders of ear

GWS hits: -

Endpoint
Case Overlap
Survival Analysis
Genetic Correlations
Genetic Signals
N (Jaccard index)
HR [CI]
Extremity
rg [CI]
Extremity
Hits
Coloc Hits
FinRegistry
FinnGen
FinRegistry
FinnGen
FinnGen
loading spinner Loading data